The primary value of placebo controls in clinical trials is the minimization of bias.

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

Lung imager 4D Medical has banked $8.4 million in an oversubscribed share purchase plan, adding to the $5.5 million raised in ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...

Microdosing psychedelics like LSD and psilocybin shows potential for enhancing mental health, creativity, and cognitive ...

A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...